Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry.
Hatice BodurFatma Gül YurdakulŞebnem AtamanHasan Fatih CayGülcan GürerErhan ÇapkınIlhan SezerMehmet Tuncay DuruözMeltem Alkan MelikogluAylin Rezvaniİlker YağcıFeride Nur GöğüşAyhan KamanliÖzgür AkgülRemzi CevikPublished in: Clinical rheumatology (2022)
NCT04139954/25.10.2019.